Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CCKAR | P32238 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10977414 | 1.00 | CCKBR (0.50) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL1236833 | 1.00 | CCKBR (0.50) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL10977417 | 1.00 | CCKBR (0.50) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL1236835 | 1.00 | CCKBR (0.50) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL27625359 | 0.99 | CCKBR (0.51) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL28317853 | 0.97 | CCKBR (0.53) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL6561026 | 0.97 | CCKBR (0.53) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL28317854 | 0.97 | CCKBR (0.53) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL6561023 | 0.97 | CCKBR (0.53) | CCKBRTDP1LMNAHSD17B10CCKAR | |
| SCHEMBL28317852 | 0.97 | CCKBR (0.53) | CCKBRTDP1LMNAHSD17B10CCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111381017-B | Five-classification hemolytic agent for white blood cells, preparation method, blood analyzer and detection method | 深圳市帝迈生物技术有限公司 | 2023-04-18 | — | — | CN | disclosed |